首页> 外国专利> Use of substances in a triple model for the treatment of degenerative and dystrophic retinal and Sehnerverkrankungen

Use of substances in a triple model for the treatment of degenerative and dystrophic retinal and Sehnerverkrankungen

机译:在三元模型中使用物质治疗退行性和营养不良性视网膜和Sehnerverkrankungen

摘要

Use of a composition comprising (a) the preparation Coenzyme Compositum, (b) the preparation Lymphomyosot and (c) the preparation Placenta Compositum as a medicament for the treatment of degenerative and dystrophic retinal and tendon contractures in a three-step model wherein the medicament is for administering an input dose by injection of (i) about 0.5 ml of the preparation Coenzyme Compositum in the area of the mastoid, (ii) about 0.5 ml of the preparation Lymphomyosot in the area of the temporal fossa and (iii) of the preparation Placenta Compositum parabulbar subcutaneously followed by 10 dose repetitions all two days once or twice a year.
机译:包含(a)辅酶复合物制剂,(b)淋巴肌球制剂和(c)胎盘复合物制剂的组合物在三步模型中作为用于治疗变性和营养不良性视网膜和肌腱挛缩的药物的用途,其中该药物用于通过(i)在乳突区域注射约0.5ml的辅酶复合物制剂,(ii)在颞窝区域注射约0.5ml的Lymphomyosot制剂和(iii)施用输入剂量。皮下胎盘胎盘的合成每年两次或每年两次,共10次。

著录项

  • 公开/公告号DE202014010456U1

    专利类型

  • 公开/公告日2015-10-23

    原文格式PDF

  • 申请/专利号DE20142010456U

  • 发明设计人

    申请日2014-06-13

  • 分类号A61K36;A61K31;A61K33;A61K35/50;A61K36/30;A61P27/02;

  • 国家 DE

  • 入库时间 2022-08-21 14:54:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号